UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials

Journal of cancer research and clinical oncology, 2018-10, Vol.144 (10), p.1851-1859

2018

Volltextzugriff (PDF)

Analysis of the clinical characteristics of 77 COVID-19 deaths

Scientific reports, 2020-10, Vol.10 (1), p.16384-16384, Article 16384

2020

Volltextzugriff (PDF)

Unique Genetic Characteristics and Clinical Prognosis of Female Patients with Lung Cancer Harboring RET Fusion Gene

Scientific reports, 2020-06, Vol.10 (1), p.10387-10387, Article 10387

2020

Volltextzugriff (PDF)

Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images

Theranostics, 2021, Vol.11 (5), p.2098-2107

2021

Volltextzugriff (PDF)

Advances in the Study of Tissue-resident Memory T Cells in Lung Cancer

Zhongguo fei ai za zhi, 2022-12, Vol.25 (12), p.862-869

2022

Volltextzugriff (PDF)

Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse

The Journal of clinical investigation, 2022-10, Vol.132 (20), p.1-16

2022

Volltextzugriff (PDF)

Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes

Journal of cancer research and clinical oncology, 2020-04, Vol.146 (4), p.935-944

2020

Volltextzugriff (PDF)

Impact of non-canonical ALK fusion on the efficacy of targeted therapy in non-small cell lung cancer

Chinese medical journal, 2024-06, Vol.137 (12), p.1468-1470

2024

Volltextzugriff (PDF)

Changes in hospitalizations for respiratory diseases following the COVID-19 epidemic

Chinese medical journal, 2022-10, Vol.135 (19), p.2386-2388

2022

Volltextzugriff (PDF)

Progress on Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2024-02, Vol.27 (2), p.138-146

2024

Volltextzugriff (PDF)

Cost-Effectiveness of Pembrolizumab for the treatment of Non–Small-Cell lung cancer: A systematic review

Frontiers in oncology, 2022-08, Vol.12, p.815587-815587

2022

Volltextzugriff (PDF)

Cost-effectiveness evaluation based on two models of first-line atezolizumab monotherapy and chemotherapy for advanced non-small cell lung cancer with high-PDL1 expression

Frontiers in oncology, 2023-03, Vol.13, p.1093469-1093469

2023

Volltextzugriff (PDF)

Characteristics of genomic alterations of lung adenocarcinoma in young never‐smokers

International journal of cancer, 2018-10, Vol.143 (7), p.1696-1705

2018

Volltextzugriff (PDF)

Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer

Clinical and experimental medicine, 2024-07, Vol.24 (1), p.162, Article 162

2024

Volltextzugriff (PDF)

A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations

Nature communications, 2022-11, Vol.13 (1), p.6944-19, Article 6944

2022

Volltextzugriff (PDF)

Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion

BMC pulmonary medicine, 2024-02, Vol.24 (1), p.89-89, Article 89

2024

Volltextzugriff (PDF)

CT-guided transthoracic core needle biopsy for small pulmonary lesions: diagnostic performance and adequacy for molecular testing

Journal of thoracic disease, 2017-02, Vol.9 (2), p.333-343

2017

Volltextzugriff (PDF)

Management of pulmonary nodules in non-high-risk population: initial evidence from a real-world prospective cohort study in China

Chinese medical journal, 2022-04, Vol.135 (8), p.994-996

2022

Volltextzugriff (PDF)

Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study

BMC cancer, 2024-03, Vol.24 (1), p.393-393, Article 393

2024

Volltextzugriff (PDF)

Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study

The Lancet. Digital health, 2022-05, Vol.4 (5), p.e309-e319

2022

Volltextzugriff (PDF)

Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing

Pathology oncology research, 2020, Vol.26 (1), p.109-114

2020

Volltextzugriff (PDF)

High PD-L1 Expression Correlates with an Immunosuppressive Tumour Immune Microenvironment and Worse Prognosis in ALK -Rearranged Non-Small Cell Lung Cancer

Biomolecules (Basel, Switzerland), 2023-06, Vol.13 (6), p.991

2023

Volltextzugriff (PDF)

A novel SLC8A1-ALK fusion in lung adenocarcinoma confers sensitivity to alectinib: A case report

Open life sciences, 2022-08, Vol.17 (1), p.846-850

2022

Volltextzugriff (PDF)

Progress of Bevacizumab in Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Zhongguo Fei Ai Za Zhi, 2019-02, Vol.22 (2), p.118-124

2019

Volltextzugriff (PDF)

Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series

Frontiers in oncology, 2021-04, Vol.11, p.633522-633522

2021

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(93)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(71)
Humans
(39)
Oncology
(35)
Lung Cancer
(25)
Female
(20)
Middle Aged
(19)
Respiratory System
(19)
Male
(18)
Lung Neoplasms - Drug Therapy
(15)
Aged
(13)
General & Internal Medicine
(13)
Immunotherapy
(13)
Adult
(12)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(12)
Medicine, General & Internal
(12)
Original
(12)
Patients
(12)
Prognosis
(12)
Lung Neoplasms - Genetics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials

Analysis of the clinical characteristics of 77 COVID-19 deaths

Unique Genetic Characteristics and Clinical Prognosis of Female Patients with Lung Cancer Harboring RET Fusion Gene

Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images

Advances in the Study of Tissue-resident Memory T Cells in Lung Cancer

Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse

Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes

Impact of non-canonical ALK fusion on the efficacy of targeted therapy in non-small cell lung cancer

Changes in hospitalizations for respiratory diseases following the COVID-19 epidemic

Progress on Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Cost-Effectiveness of Pembrolizumab for the treatment of Non–Small-Cell lung cancer: A systematic review

Cost-effectiveness evaluation based on two models of first-line atezolizumab monotherapy and chemotherapy for advanced non-small cell lung cancer with high-PDL1 expression

Characteristics of genomic alterations of lung adenocarcinoma in young never‐smokers

Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer

A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations

Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion

CT-guided transthoracic core needle biopsy for small pulmonary lesions: diagnostic performance and adequacy for molecular testing

Management of pulmonary nodules in non-high-risk population: initial evidence from a real-world prospective cohort study in China

Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study

Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study

Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing

High PD-L1 Expression Correlates with an Immunosuppressive Tumour Immune Microenvironment and Worse Prognosis in ALK -Rearranged Non-Small Cell Lung Cancer

A novel SLC8A1-ALK fusion in lung adenocarcinoma confers sensitivity to alectinib: A case report

Progress of Bevacizumab in Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series

Suchergebnisse filtern